The role of probiotics in the prevention of necrotizing enterocolitis.

Necrotizing enterocolitis (NEC) is a frequent and severe life-threatening disease affecting the gastrointestinal tract of preterm infants. Given that NEC occurs in a well-defined population of patients, there might be a considerable benefit in identifying specific pharmacological and nutritional preventive strategies, that could reduce the incidence of NEC. Amongst nutritional strategies emphasis has been put on the use of probiotics. Therefore, the aim of this review is to summarize currently available evidence on the role of probiotics in general, as well as the role of specific probiotic strains or their combinations, in the prevention of NEC.

[1]  H. Szajewska,et al.  Probiotics for Preterm Infants: A Strain-Specific Systematic Review and Network Meta-analysis , 2018, Journal of pediatric gastroenterology and nutrition.

[2]  S. Eaton,et al.  Probiotics and necrotizing enterocolitis , 2022 .

[3]  S. Patole,et al.  Bifidobacterium breve M‐16V as a Probiotic for Preterm Infants: A Strain‐Specific Systematic Review , 2017, JPEN. Journal of parenteral and enteral nutrition.

[4]  H. Szajewska,et al.  Commercial Probiotic Products: A Call for Improved Quality Control. A Position Paper by the ESPGHAN Working Group for Probiotics and Prebiotics. , 2017, Journal of pediatric gastroenterology and nutrition.

[5]  M. Underwood,et al.  The Microbiota of the Extremely Preterm Infant , 2017, Clinics in Perinatology.

[6]  T. Denning,et al.  Pathogenesis of NEC: Role of the innate and adaptive immune response. , 2017, Seminars in perinatology.

[7]  M. Kleerebezem,et al.  Can probiotics modulate human disease by impacting intestinal barrier function? , 2017, The British journal of nutrition.

[8]  J. Ibana,et al.  Addressing the Antibiotic Resistance Problem with Probiotics: Reducing the Risk of Its Double-Edged Sword Effect , 2016, Front. Microbiol..

[9]  D. Hackam,et al.  Necrotizing enterocolitis: new insights into pathogenesis and mechanisms , 2016, Nature Reviews Gastroenterology &Hepatology.

[10]  S. Patole,et al.  Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review. , 2016, JPEN. Journal of parenteral and enteral nutrition.

[11]  K. Costeloe,et al.  A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial. , 2016, Health technology assessment.

[12]  P. Gastmeier,et al.  Protective Effect of Dual-Strain Probiotics in Preterm Infants: A Multi-Center Time Series Analysis , 2016, PloS one.

[13]  G. Weinstock,et al.  Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study , 2016, The Lancet.

[14]  M. Underwood,et al.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant. , 2016, Clinical therapeutics.

[15]  A. Shane,et al.  Advancing probiotic research in humans in the United States: Challenges and strategies , 2016, Gut microbes.

[16]  G. Greisen,et al.  Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies , 2015, Neonatology.

[17]  M. Underwood,et al.  Validating bifidobacterial species and subspecies identity in commercial probiotic products , 2015, Pediatric Research.

[18]  L. Morelli,et al.  Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis , 2015, Italian Journal of Pediatrics.

[19]  Danielle G. Lemay,et al.  Bifidobacteria grown on human milk oligosaccharides downregulate the expression of inflammation-related genes in Caco-2 cells , 2015, BMC Microbiology.

[20]  A. Moore,et al.  Low birthweight, gestational age, need for surgical intervention and gram‐negative bacteraemia predict intestinal failure following necrotising enterocolitis , 2015, Acta paediatrica.

[21]  Christine S. M. Lau,et al.  Probiotic administration can prevent necrotizing enterocolitis in preterm infants: A meta-analysis. , 2015, Journal of pediatric surgery.

[22]  C. Bertelli,et al.  Bifidobacterium longum bacteremia in preterm infants receiving probiotics. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  S. Lockhart,et al.  Fatal Gastrointestinal Mucormycosis in a Premature Infant Associated with a Contaminated Dietary Supplement — Connecticut, 2014 , 2015, MMWR. Morbidity and mortality weekly report.

[24]  R. Zbinden,et al.  Case Series of Bifidobacterium longum Bacteremia in Three Preterm Infants on Probiotic Therapy , 2014, Neonatology.

[25]  S. Patole,et al.  Benefits of probiotics on enteral nutrition in preterm neonates: a systematic review. , 2014, The American journal of clinical nutrition.

[26]  William D. Shannon,et al.  Patterned progression of bacterial populations in the premature infant gut , 2014, Proceedings of the National Academy of Sciences.

[27]  Y. Guo,et al.  A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates , 2014, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[28]  Glenn R. Gibson,et al.  The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic , 2014 .

[29]  K. Kalanetra,et al.  Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota , 2014, Pediatric Research.

[30]  S. Patole,et al.  Probiotics for Preterm Neonates: What Will It Take to Change Clinical Practice? , 2013, Neonatology.

[31]  R. Christensen,et al.  Necrotizing enterocolitis in term infants. , 2013, Clinics in perinatology.

[32]  Zhang Dongya,et al.  Deep 16S rRNA metagenomics and quantitative PCR analyses of the premature infant fecal microbiota. , 2012, Anaerobe.

[33]  A. Nusrat,et al.  Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Probiotic Bacteria Induce Maturation of Intestinal Claudin 3 Expression and Barrier Function , 2012 .

[34]  P. Manzoni,et al.  Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. , 2011, Early human development.

[35]  B. Poindexter,et al.  Neonatal Outcomes of Extremely Preterm Infants From the NICHD Neonatal Research Network , 2010, Pediatrics.

[36]  M. Bulsara,et al.  Updated Meta-analysis of Probiotics for Preventing Necrotizing Enterocolitis in Preterm Neonates , 2010, Pediatrics.

[37]  C. Gómez-Llorente,et al.  International Immunonutrition Workshop Session 5 : Early programming of the immune system and the role of nutrition Role of Toll-like receptors in the development of immunotolerance mediated by probiotics , 2010 .

[38]  N. Murthy,et al.  Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. , 2009, Free radical biology & medicine.

[39]  D. Antonopoulos,et al.  16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis , 2009, The ISME Journal.

[40]  A. Neish,et al.  The Bacterial Fermentation Product Butyrate Influences Epithelial Signaling via Reactive Oxygen Species-Mediated Changes in Cullin-1 Neddylation1 , 2009, The Journal of Immunology.

[41]  E. Claud,et al.  Bacterial Colonization, Probiotics, and Necrotizing Enterocolitis , 2008, Journal of clinical gastroenterology.

[42]  W. Walker.  Mechanisms of action of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  D. Hackam,et al.  A Critical Role for TLR4 in the Pathogenesis of Necrotizing Enterocolitis by Modulating Intestinal Injury and Repair1 , 2007, The Journal of Immunology.

[44]  R. Thomson,,et al.  The Roles of Bacteria and TLR4 in Rat and Murine Models of Necrotizing Enterocolitis1 , 2006, The Journal of Immunology.

[45]  M. Tang,et al.  Probiotic use in clinical practice: what are the risks? , 2006, The American journal of clinical nutrition.

[46]  K. Lui,et al.  Epidemiology of necrotizing enterocolitis – Part II: Risks and susceptibility of premature infants during the surfactant era: A regional study , 2005, Journal of paediatrics and child health.

[47]  M. Fairchok,et al.  Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. , 2004, Journal of pediatric gastroenterology and nutrition.

[48]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[49]  T. Jilling,et al.  Pathogenesis of necrotizing enterocolitis: modeling the innate immune response. , 2015, The American journal of pathology.

[50]  J. Neu,et al.  Necrotizing enterocolitis. , 2011, The New England journal of medicine.